Handling hazardous drugs (HDs) presents ongoing risks across the entire medication-use process from receiving and compounding to administration and waste disposal. Studies have shown that surface contamination with antineoplastic drugs can occur at every stage, exposing pharmacists, nurses, and support staff to potential health risks. The BD® HD Check System is designed to address this challenge by providing a portable, on-demand testing solution that helps healthcare organizations quickly identify contamination and take corrective action.
The system features a handheld, easy-to-use design that allows staff to test surfaces for select hazardous drug residues anywhere within the facility. Results are delivered in less than 10 minutes, enabling immediate response to contamination events and helping prevent the spread of hazardous drug exposure. This real-time visibility is critical in environments where even trace amounts of HD residue can pose risks, including DNA damage, increased cancer rates, organ toxicity, and reproductive health concerns among healthcare workers.
By enabling routine monitoring and rapid detection, the BD® HD Check System supports safer handling practices and reinforces compliance with USP <800> guidelines. It empowers pharmacy and clinical teams to proactively identify contamination points, whether in the pharmacy, patient care areas, or transport pathways, and implement targeted cleaning and safety protocols.
Key Capabilities of the BD® HD Check System:
- Handheld, portable design for on-site surface testing
- Results in under 10 minutes for rapid decision-making
- Detection of hazardous drug residue across multiple workflow stages
- Supports USP <800> compliance and contamination control strategies
- Helps reduce occupational exposure risks for healthcare staff
